Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Regulus Therapeutics Inc. logo

Regulus Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

2.88
 
USD
  
0.04
  
(1.23%)
Optionable: Yes  Market Cap: 186 M  90-day average vol: 3,052,804

Previous close: 2.845  Open: 2.88  Bid: 2.73  Ask: 2.88
52 week range    
0.78   
   3.79
Peers   
SNY / 
ALNY / 
GSK / 
BIIB / 
BMY / 
SGMO / 
Last updated: Thursday 28th March 2024
56
MarketXLS Rank
55
Value
69
Technical
44
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ALNY

17 B-19.3148.65

AZN

BIIB

34 B21.6221.3

BMY

0.0332145 B-27.366.19

GSK

SGMO

1 B-4.75.72

SNY

Financials

RGLS Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-100000.0-100000.0-100000.0-100000.0-100000.0-100000.0-100000.0100000.0100000.0100000.0
Basic EPS from continuing operations-4.5-3.21.86
Basic EPS total-4.5-3.21.86
Basic weighted shares outstanding3,848 M4,409 M5 M5 M8 M871856.02 M3 M9 M15 M
Depreciation-1 M-2 M-2 M-3 M-2 M-931000.0500000.0459000.0
Depreciation unreconciled-1 M-1 M
DepreciationAndAmortization-1 M-1 M-2 M-2 M-3 M-2 M-931000.0500000.0459000.0
Diluted EPS total-4.9-12.9-10.8-15.5-9.6-55.9-10.8-4.5-3.21.86
Diluted normalized net income/share-3.21.86
Diluted weighted shares outstanding4 M4 M5 M5 M7 M871359.02 M3 M9 M15 M
GainOnSaleOfPPE-2 M
GainOnSaleOfSecurity42000.03000.0-2 M
GeneralAndAdministrativeExpense7 M12 M19 M18 M17 M13 M11 M9 M10 M10 M
Gross operating profit20 M8 M21 M1 M72000.072000.07 M10 M
Income before tax-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M
Income restructuring and M&A-4 M
Income taxes-23000.01000.0-18000.0-4000.0-197000.062000.01000.0-927000.01000.01000.0
Interest income292000.0388000.0855000.0844000.0752000.0459000.0374000.0233000.0864000.0605000.0
InterestExpenseNonOperating36000.039000.052000.01 M3 M2 M2 M2 M855000.0688000.0
MiscOtherSpecialCharges-1 M-12 M-2 M
Net income from total operations-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M
NetIncomeCommonStockholders-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M
NetIncomeContinuousOperations-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M
NetNonOperatingInterestIncomeExpense256000.0349000.0803000.0-338000.0-2 M-2 M-2 M-2 M9000.0-83000.0
Normalized income-22 M
Operating income-18 M-45 M-55 M-82 M-70 M-47 M-17 M-14 M-28 M-28 M
Operating income before depreciation (EBITDA)-16 M-54 M-53 M-78 M-67 M-44 M-16 M-13 M-26 M-28 M
OperatingExpense-37 M-53 M-76 M-83 M-70 M-47 M-24 M24 M28 M28 M
Other income net1 M12 M2 M2 M2 M
OtherGandA7 M12 M19 M18 M17 M13 M11 M9 M10 M10 M
OtherOperatingExpenses-37 M-53 M-76 M-83 M-70 M-47 M-24 M-1 M-188000.0-295000.0
RentAndLandingFees7 M12 M19 M18 M17 M13 M11 M
Research & development expense30 M41 M56 M64 M53 M34 M12 M15 M18 M18 M
ResearchExpense30 M41 M56 M64 M53 M34 M12 M15 M18 M18 M
RestructringAndMnAIncome-4 M
Revenue per share-100000.0-100000.0-100000.0-100000.0-100000.0-100000.0-182000.0278000.0129000.0100000.0
SalariesAndWages-3 M-7 M-15 M-13 M-8 M-5 M-2 M
Selling Gen & administrative expense7 M12 M19 M18 M17 M13 M11 M9 M10 M10 M
Special income/charges4 M
Total Income available for interest expense (EBIT)-19 M-57 M-56 M-81 M-69 M-46 M-16 M-14 M-27 M-28 M
Total common shares outstanding359733.0420972.0439206.0441103.0866325.01 M2 M7 M15 M17 M
Total net income-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M-28 M
Total ordinary shares20 M20 M20 M20 M20 M20 M20 M20 M20 M20 M
Total revenues20 M8 M21 M1 M72000.072000.07 M10 M
TotalExpenses-37 M-53 M-76 M-83 M-70 M-47 M-24 M24 M28 M28 M
TotalRevenue20 M8 M21 M1 M72000.072000.07 M10 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University